Back to Carlyle Group Inc. Carlyle Group Inc.

JSPRJSPR
Showing 8 of 14 quarters

Position history for Carlyle Group Inc.Carlyle Group Inc.'s holdings in JASPER THERAPEUTICS INC

Carlyle Group Inc. holds 1.1M shares of JSPR (JASPER THERAPEUTICS INC), worth $448,866 as of 2026-Q2. JSPR represents 0.0% of Carlyle Group Inc.'s portfolio.

Current Value

$448,866

Current Shares

1.1M

Total Value Change

-$19.4M

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
1.1M
0.0%
$448,8660.0%$0.42
0
2026-Q1
Unchanged
1.1M
0.0%
$934,1950.0%$1.33
0
2025-Q4
Unchanged
1.1M
0.0%
$1.9M0.0%$1.79
0
2025-Q3
Unchanged
1.1M
0.0%
$2.5M0.1%$2.49
0
2025-Q2
Unchanged
1.1M
0.0%
$5.9M0.1%$5.49
0
2025-Q1
Unchanged
1.1M
0.0%
$4.6M0.1%$4.46
0
2024-Q4
Unchanged
1.1M
0.0%
$22.7M0.5%$20.95
0
2024-Q3
Unchanged
1.1M
0.0%
$19.9M2.1%$18.83
0

Other major holders of JSPR: CITADEL ADVISORS LLC, FRANKLIN RESOURCES INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used